WilsonSColucciMD

Cardiology • Boston, MA

Adult Congenital Heart Disease, Heart Failure & Transplantation

Professor of Medicine, Boston University

Join to view full profile

Dr. Colucci is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Colucci's full profile

Already have an account?

Office
732 Harrison Ave
3RD floor
Boston, MA 02118
Phone+1 617-638-7490

Fax+1 617-414-8742

Education & Training

Brigham and Women's HospitalResidency, Internal Medicine, 1980 - 1981
Brigham and Women's HospitalFellowship, Cardiovascular Disease, 1978 - 1980
Brigham and Women's HospitalResidency, Internal Medicine, 1975 - 1978
Boston University School of MedicineClass of 1975

Certifications & Licensure

MA State Medical License 1979 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

Boston Magazine Castle Connolly, 2011-2013
Elected Member The American Society for Clinical Investigation, 1988
Super Doctor SuperDoctors.com
Fellow (FACC) American College of Cardiology
Join now to see all

Clinical Trials

A Dose-Defining Study of CXL-1020 in Patients With Systolic Heart Failure Start of enrollment: 2010 Apr 01
Completed
Phase 2

Publications & Presentations

PubMed

9 citations
SGLT2 inhibitor ertugliflozin decreases elevated intracellular sodium, and improves energetics and contractile function in diabetic cardiomyopathy.
Dominique Croteau, Tomas Baka, Sara Young, Huamei He, Jordan M Chambers
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 2023-04-01
36 citations
Effects of Sodium-Glucose Linked Transporter 2 Inhibition With Ertugliflozin on Mitochondrial Function, Energetics, and Metabolic Gene Expression in the Presence and A...
Dominique Croteau, Ivan Luptak, Jordan M. Chambers, Ion A. Hobai, Marcello Panagia
Journal of the American Heart Association. 2021-07-06
21 citations
Redox-Resistant SERCA [Sarco(endo)plasmic Reticulum Calcium ATPase] Attenuates Oxidant-Stimulated Mitochondrial Calcium and Apoptosis in Cardiac Myocytes and Pressure ...
Jena B Goodman, Fuzhong Qin, Robert J. Morgan, Jordan M. Chambers, Dominique Croteau
Circulation. 2020-12-22

Other

Calcium channel blockers in heart failure due to systolic dysfunction
Colucci WS
http://www.uptodate.com/contents/calcium-channel-blockers-in-heart-failure-due-to-systolic-dysfuncti
UpToDate, Wolters Kluwer Health - 2012-02-29
Rationale for and clinical trials of beta blockers in heart failure due to systolic dysfunction
Colucci WS
http://www.uptodate.com/contents/rationale-for-and-clinical-trials-of-beta-blockers-in-heart-failure
UpToDate, Wolters Kluwer Health - 2012-10-16
Impact of anemia in patients with heart failure
Colucci WS
http://www.uptodate.com/contents/impact-of-anemia-in-patients-with-heart-failure
UpToDate, Wolters Kluwer Health - 2013-03-19
Natriuretic peptide measurement in heart failure
Colucci WS, Chen HH
http://www.uptodate.com/contents/natriuretic-peptide-measurement-in-heart-failure
UpToDate, Wolters Kluwer Health - 2012-04-20
Natriuretic peptide measurement in non-heart failure settings
Colucci WS, Chen HH
http://www.uptodate.com/contents/natriuretic-peptide-measurement-in-non-heart-failure-settings
UpToDate, Wolters Kluwer Health - 2013-01-28
Predictors of survival in heart failure due to systolic dysfunction
Colucci WS
http://www.uptodate.com/contents/predictors-of-survival-in-heart-failure-due-to-systolic-dysfunction
UpToDate, Wolters Kluwer Health - 2012-01-25
Nitric oxide, other hormones, cytokines, and chemokines in heart failure
Colucci WS
http://www.uptodate.com/contents/nitric-oxide-other-hormones-cytokines-and-chemokines-in-heart-failu
UpToDate, Wolters Kluwer Health - 2012-11-19
Pathophysiology of heart failure: Left ventricular pressure-volume relationships
Colucci WS
http://www.uptodate.com/contents/pathophysiology-of-heart-failure-left-ventricular-pressure-volume-r
UpToDate, Wolters Kluwer Health - 2012-11-01
Pathophysiology of heart failure: Neurohumoral adaptations
Colucci WS
http://www.uptodate.com/contents/pathophysiology-of-heart-failure-neurohumoral-adaptations
UpToDate, Wolters Kluwer Health - 2012-03-07
Skeletal muscle dysfunction and exercise intolerance in heart failure
Colucci WS
http://www.uptodate.com/contents/skeletal-muscle-dysfunction-and-exercise-intolerance-in-heart-failu
UpToDate, Wolters Kluwer Health - 2012-01-27
Renal effects of ACE inhibitors in heart failure
Colucci WS
http://www.uptodate.com/contents/renal-effects-of-ace-inhibitors-in-heart-failure
UpToDate, Wolters Kluwer Health - 2012-03-19
Drugs that should be avoided or used with caution in patients with heart failure
Colucci WS
http://www.uptodate.com/contents/drugs-that-should-be-avoided-or-used-with-caution-in-patients-with-
UpToDate, Wolters Kluwer Health - 2012-08-24
Genetic and cellular therapy in heart failure and myocardial infarction
Colucci WS, Simons M
http://www.uptodate.com/contents/genetic-and-cellular-therapy-in-heart-failure-and-myocardial-infarc
UpToDate, Wolters Kluwer Health - 2013-04-09
Hydralazine plus nitrate therapy in patients with heart failure due to systolic dysfunction
Colucci WS
http://www.uptodate.com/contents/hydralazine-plus-nitrate-therapy-in-patients-with-heart-failure-due
UpToDate, Wolters Kluwer Health - 2012-08-21
Management of refractory heart failure
Colucci WS
http://www.uptodate.com/contents/management-of-refractory-heart-failure
UpToDate, Wolters Kluwer Health - 2012-09-07
Possibly effective emerging therapies for heart failure
Colucci WS
http://www.uptodate.com/contents/possibly-effective-emerging-therapies-for-heart-failure
UpToDate, Wolters Kluwer Health - 2013-01-10
Treatment of acute decompensated heart failure in acute coronary syndromes
Colucci WS
http://www.uptodate.com/contents/treatment-of-acute-decompensated-heart-failure-in-acute-coronary-sy
UpToDate, Wolters Kluwer Health - 2012-01-06
Unproven therapies for chronic systolic heart failure
Colucci WS
http://www.uptodate.com/contents/unproven-therapies-for-chronic-systolic-heart-failure
UpToDate, Wolters Kluwer Health - 2012-09-07
Dobutamine stress echocardiography in the evaluation of hibernating myocardium
Colucci WS
http://www.uptodate.com/contents/dobutamine-stress-echocardiography-in-the-evaluation-of-hibernating
UpToDate, Wolters Kluwer Health - 2012-09-19
Indications for antithrombotic therapy in heart failure
Colucci WS, Lip GY
http://www.uptodate.com/contents/indications-for-antithrombotic-therapy-in-heart-failure
UpToDate, Wolters Kluwer Health - 2013-04-03
Overview of the therapy of heart failure due to systolic dysfunction
Colucci WS
http://www.uptodate.com/contents/overview-of-the-therapy-of-heart-failure-due-to-systolic-dysfunctio
UpToDate, Wolters Kluwer Health - 2012-12-10
Treatment of acute decompensated heart failure: Components of therapy
Colucci WS
http://www.uptodate.com/contents/treatment-of-acute-decompensated-heart-failure-components-of-therap
UpToDate, Wolters Kluwer Health - 2013-04-01
Treatment of acute decompensated heart failure: General considerations
Colucci WS
http://www.uptodate.com/contents/treatment-of-acute-decompensated-heart-failure-general-consideratio
UpToDate, Wolters Kluwer Health - 2012-11-19
ACE inhibitors in heart failure due to systolic dysfunction: Therapeutic use
Colucci WS
http://www.uptodate.com/contents/ace-inhibitors-in-heart-failure-due-to-systolic-dysfunction-therape
UpToDate, Wolters Kluwer Health - 2012-09-13
Alcoholic cardiomyopathy
Colucci WS, Rafie IM
http://www.uptodate.com/contents/alcoholic-cardiomyopathy
UpToDate, Wolters Kluwer Health - 2012-12-21
Join now to see all

Authored Content

The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure — NEJMMay 1996

Press Mentions

Mitochondria Studies Critical to Search for Heart Failure CureOctober 2nd, 2019

Grant Support

Oxidative Stress In Myocardial Remodeling And FailureNational Heart, Lung, And Blood Institute2001–2011
Mechanisms Of Oxidant Signaling In Post-Mi RemodelingNational Heart, Lung, And Blood Institute2004–2007
Action - A CHF Trial Investigating Outcomes Of ExerciseNational Heart, Lung, And Blood Institute2004–2007
Myocaridal Remodeling By Hemodynamic OverloadNational Heart, Lung, And Blood Institute2000–2002
NO &02-In Postmyocardial Infarction Remodeling &FaNational Heart, Lung, And Blood Institute1998–2002
Regulation Of Vascular Alpha1--Adrenergic ResponsesNational Heart, Lung, And Blood Institute1996–2000
Cardiovascular Control By Nitric Oxide In Heart FailureNational Heart, Lung, And Blood Institute1995–1999
Regulation Of Vascular Alpha-1 Adrenergic ResponsesNational Heart, Lung, And Blood Institute1989–1993